FNSGp: Difference between revisions
From Bioblast
No edit summary |
No edit summary ย |
||
(3 intermediate revisions by 3 users not shown) | |||
Line 10: | Line 10: | ||
This substrate combination supports convergent electron flow to the [[Q-junction]]. | This substrate combination supports convergent electron flow to the [[Q-junction]]. | ||
|info=[[MiPNet21.06 SUIT | |info=[[MiPNet21.06 SUIT RP]], [[Gnaiger 2020 BEC MitoPathways]] | ||
}} | }} | ||
::: ''More details'' ย | ::: ''More details'' ย | ||
Line 22: | Line 19: | ||
== FNSGp<sub>''P''</sub> == | == FNSGp<sub>''L''</sub> == | ||
FNSGp pathway in the LEAK state can be evaluated in the following SUIT protocols: | |||
ย | |||
== FNSGp<sub>''P''</sub>== | |||
FNSGp pathway in the OXPHOS state can be evaluated in the following SUIT protocols: | FNSGp pathway in the OXPHOS state can be evaluated in the following SUIT protocols: | ||
:::*[[SUIT-002]] | :::*[[SUIT-002]] | ||
::::* DL-Protocol for isolated mitochondria and tissue homogenate (mt): [[SUIT-002 O2 mt D005]] | ::::* DL-Protocol for isolated mitochondria and tissue homogenate (mt): [[SUIT-002 O2 mt D005]] | ||
::::* DL-Protocol for permeabilized fibers (pfi): [[SUIT-002 O2 pfi D006]] | ::::* DL-Protocol for permeabilized fibers (pfi): [[SUIT-002 O2 pfi D006]] | ||
::::* DL-Protocol for permeabilized cells (pce): [[SUIT-002 O2 pce D007]] | ::::* DL-Protocol for permeabilized cells (pce): [[SUIT-002 O2 ce-pce D007]] | ||
== FNSGp pathway in the | == FNSGp<sub>''E''</sub>== | ||
FNSGp pathway in the ET state can be evaluated in the following SUIT protocols: | |||
:::*[[SUIT-002]] | :::*[[SUIT-002]] | ||
::::* | ::::* DL-Protocol for isolated mitochondria and tissue homogenate (mt): [[SUIT-002 O2 mt D005]] | ||
::::* DL-Protocol for permeabilized fibers (pfi): [[SUIT-002 O2 pfi D006]] | |||
::::* DL-Protocol for permeabilized cells (pce): [[SUIT-002 O2 ce-pce D007]] | |||
ย | |||
ย | |||
::::* | |||
::::* | |||
Line 52: | Line 40: | ||
[[File:SUIT-Reference-Protocol 2.jpg|700px |SUIT RP2]] | [[File:SUIT-Reference-Protocol 2.jpg|700px |SUIT RP2]] | ||
---- | ---- | ||
{{MitoPedia concepts | |||
|mitopedia concept=SUIT state | |||
}} |
Latest revision as of 04:54, 19 July 2022
Description
MitoPathway control state: FNSGp
- Octanoylcarnitine or Palmitoylcarnitine & Pyruvate &/or Glutamate & Malate & Succinate & Glycerophosphate.
SUIT protocol: SUIT-002
This substrate combination supports convergent electron flow to the Q-junction.
Abbreviation: FNSGp
Reference: MiPNet21.06 SUIT RP, Gnaiger 2020 BEC MitoPathways
FNSGpL
FNSGp pathway in the LEAK state can be evaluated in the following SUIT protocols:
FNSGpP
FNSGp pathway in the OXPHOS state can be evaluated in the following SUIT protocols:
-
- DL-Protocol for isolated mitochondria and tissue homogenate (mt): SUIT-002 O2 mt D005
- DL-Protocol for permeabilized fibers (pfi): SUIT-002 O2 pfi D006
- DL-Protocol for permeabilized cells (pce): SUIT-002 O2 ce-pce D007
-
FNSGpE
FNSGp pathway in the ET state can be evaluated in the following SUIT protocols:
-
- DL-Protocol for isolated mitochondria and tissue homogenate (mt): SUIT-002 O2 mt D005
- DL-Protocol for permeabilized fibers (pfi): SUIT-002 O2 pfi D006
- DL-Protocol for permeabilized cells (pce): SUIT-002 O2 ce-pce D007
-
MitoPedia concepts:
SUIT state